BNP Paribas Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.5M | Buy |
712,719
+101,880
| +17% | +$2.93M | 0.05% | 347 |
|
|
2025
Q1 | $20.5M | Buy |
610,839
+34,771
| +6% | +$1.17M | 0.05% | 336 |
|
|
2024
Q4 | $29.5M | Buy |
576,068
+84,687
| +17% | +$4.33M | 0.07% | 263 |
|
|
2024
Q3 | $25.1M | Sell |
491,381
-54,853
| -10% | -$2.8M | 0.06% | 271 |
|
|
2024
Q2 | $24.5M | Buy |
546,234
+3,526
| +0.6% | +$158K | 0.06% | 267 |
|
|
2024
Q1 | $25.4M | Sell |
542,708
-115,581
| -18% | -$5.41M | 0.07% | 272 |
|
|
2023
Q4 | $23.4M | Buy |
658,289
+24,925
| +4% | +$887K | 0.07% | 280 |
|
|
2023
Q3 | $18.8M | Sell |
633,364
-7,981
| -1% | -$237K | 0.06% | 301 |
|
|
2023
Q2 | $11.6M | Sell |
641,345
-49,856
| -7% | -$898K | 0.04% | 380 |
|
|
2023
Q1 | $11.1M | Buy |
691,201
+80,511
| +13% | +$1.29M | 0.04% | 406 |
|
|
2022
Q4 | $11.2M | Buy |
610,690
+155,271
| +34% | +$2.84M | 0.04% | 401 |
|
|
2022
Q3 | $8.94M | Buy |
+455,419
| New | +$8.94M | 0.04% | 430 |
|